000 01647nam a2200421 i 4500
001 ocn960809637
003 OCoLC
005 20170208053812.0
006 m o d f
007 cr mn|||||||||
008 161017s1995 dcua ob f000 0 eng c
040 _aGPO
_beng
_erda
_epn
_cGPO
042 _apcc
043 _an-us---
074 _a0445-B-07 (online)
086 0 _aHE 1.75:OEI-05-94-00130
088 _aOEI-05-94-00130
099 _aHE 1.75:OEI-05-94-00130
110 1 _aUnited States.
_bDepartment of Health and Human Services.
_bOffice of Inspector General,
_eauthor.
245 1 0 _aCLIA's impact on the availability of laboratory services.
246 3 _aClinical Laboratory Improvement Amendments impact on the availability of laboratory services
264 1 _a[Washington, D.C.] :
_bDepartment of Health and Human Services, Office of Inspector General,
_c1995.
300 _a1 online resource ([51] pages) :
_billustrations
337 _2rdamedia
338 _2rdacarrier
500 _aTitle from title screen (viewed Oct. 14, 2016).
500 _a"June 1995."
500 _a"OEI-05-94-00130."
500 _aCRDP Project record.
504 _aIncludes bibliographical references.
650 0 _aMedicare.
650 0 _aMedical laboratories
_zUnited States.
650 0 _aDiagnosis, Laboratory
_zUnited States.
610 1 0 _aUnited States.
_tClinical Laboratory Improvement Amendments of 1988.
776 0 8 _iPrint version:
_tCLIA's impact on the availability of laboratory services
_w(OCoLC)768191894
856 4 0 _uhttp://purl.fdlp.gov/GPO/gpo73471
949 _aBEV
_bFed Docs
999 _c257039
_d257039